--- 
layout: page 
image:
  feature: DaubEnginePatent.jpg
--- 
   <head>
      <title>1865-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-1800.html"><span>Chapter 1800</span></a></li>
      <li><span>Section 1865</span></li>  </ul>  </div>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e183487">
                     <h1 class="page-title">1865
                        &nbsp;&nbsp;
                        Filing of Demand [R-08.2012]
                     </h1>
                     <div class="" id="d0e183491">
                        <h4 class="PCT"><i>PCT Article&nbsp;31</i></h4>
                        <h4><i>Demand for International Preliminary
                              					Examination</i></h4>
                        <ul style="list-style-type: none;">
                           <li id="d0e183500" class="nobull">(1) On the demand of the
                              							applicant, his international application shall be the subject of an
                              							international preliminary examination as provided in the following
                              							provisions and the Regulations.
                           </li>
                        </ul>
                        <p class="excludedText"> ***** 
                           
                        </p>
                        <ul style="list-style-type: none;">
                           <li id="d0e183507" class="nobull">(3) The demand for
                              							international preliminary examination shall be made separately from the
                              							international application. The demand shall contain the prescribed
                              							particulars and shall be in the prescribed language and
                              							form.
                           </li>
                        </ul>
                        <p class="excludedText"> ***** 
                           
                        </p>
                        <ul style="list-style-type: none;">
                           <li id="d0e183514" class="nobull">(6)
                              <ul style="list-style-type: none;">
                                 <li id="d0e183515" class="nobull">(a)  The demand
                                    									shall be submitted to the competent International Preliminary
                                    									Examining Authority referred to in <b><a href="mpep-9025-appx-t.html#d0e364050">Article 32</a></b>
                                    									. 
                                 </li>
                              </ul>
                           </li>
                        </ul>
                        <p class="excludedText"> ***** 
                           
                        </p>
                     </div>
                     <p id="d0e183524"> Applicants should submit the Demand
                        			and appropriate fees directly to the International Preliminary Examining Authority
                        			(IPEA) they desire to prepare the International Preliminary Examination Report. United
                        			States applicants who have had the international search prepared by the European Patent
                        			Office (EPO) may request the EPO to act as the IPEA with some exceptions. See MPEP §
                        				<b><a href="s1865.html#d0e183713">1865.01</a></b> . 
                     </p>
                     <p id="d0e183535">Demands filed in the European Patent
                        			Office should be delivered to the European Patent Office Headquarters at
                        			Munich:
                     </p>
                     <p id="d0e183538">Location:</p>
                     <p style="margin-left: 25pt;">Erhardstr. 27<br>D-80331 Munchen<br>Germany
                     </p>
                     <p id="d0e183551">Mailing address:</p>
                     <p style="margin-left: 25pt;">D-80298 Munchen<br>Germany
                     </p>
                     <p id="d0e183561">United States applicants may also
                        			request the Korean Intellectual Property Office (KIPO) to act as the IPEA. Demands filed
                        			in the KIPO should be delivered to the KIPO Headquarters:
                     </p>
                     <p id="d0e183564">Location and mailing
                        			address:
                     </p>
                     <p style="margin-left: 25pt;">920 Dunsan-dong<br>Seo-gu, Daejeon Metropolitan City 302-701<br>Republic of Korea
                     </p>
                     <p id="d0e183577">Demands filed in the United States
                        			Patent and Trademark Office (USPTO) should be addressed as follows:
                     </p>
                     <p id="d0e183580">Mailing address for delivery by the
                        			U.S. Postal Service:
                     </p>
                     <p style="margin-left: 25pt;">Mail Stop PCT<br>Commissioner for Patents<br>P.O. Box 1450<br>Alexandria, VA 22313-1450.<br></p>
                     <p id="d0e183596">OR</p>
                     <p id="d0e183599">If hand-carried directly to the
                        			USPTO:
                     </p>
                     <p style="margin-left: 25pt;">Customer Service Window, Mail Stop
                        				PCT<br>Randolph Building<br>401 Dulany Street<br>Alexandria, VA 22314<br></p>
                     <p id="d0e183615"> The “Express Mail” provisions of
                        				<b><a href="mpep-9020-appx-r.html#d0e313951">37 CFR 1.10</a></b> may be used to file a Demand under Chapter II in
                        			the&nbsp;USPTO. Applicants are advised that failure to comply with the provisions of
                        				<b><a href="mpep-9020-appx-r.html#d0e313951">37 CFR 1.10</a></b> will result in the paper or fee being accorded the
                        			date of receipt and not the date of deposit. See <b><a href="s513.html#d0e33501">MPEP § 513</a></b> . 
                     </p>
                     <p id="d0e183627"> Demand for international preliminary
                        			examination may also be submitted to the USPTO via internet (EFS-Web) or facsimile. The
                        			Certificate of Mailing or Transmission practice under <b><a href="mpep-9020-appx-r.html#d0e313726">37 CFR
                              				1.8</a></b> CANNOT be used to file a Demand if the date of deposit is
                        			desired. If used, the date of the Demand will be the date of receipt in the USPTO. See
                        				<b><a href="s513.html#d0e33501">MPEP
                              				§ 513</a></b> , <b><a href="s1834.html#d0e170737">§ 1834</a></b> , and
                        				<b><a href="s1834.html#d0e170909">§&nbsp;1834.01</a></b> . 
                     </p>
                     <p id="d0e183650">All Demands filed in the USPTO must
                        			be in the English language.
                     </p>
                     <p id="d0e183653"><b><a href="mpep-9025-appx-t.html#d0e374126">PCT
                              				Rule 59.3</a></b> was amended July 1, 1998 to provide a safeguard in the
                        			case of a Demand filed with an International Preliminary Examining Authority which is
                        			not competent for the international preliminary examination of a particular
                        			international application. The USPTO will forward such a Demand to the International
                        			Bureau and the International Bureau will forward the Demand to a competent International
                        			Preliminary Examining Authority pursuant to <b><a href="mpep-9025-appx-t.html#d0e374126">PCT Rule 59.3(c)</a></b> .
                        			The competent International Preliminary Examining Authority will process the Demand
                        			based on the date of receipt in the USPTO. See <b><a href="mpep-9020-appx-r.html#d0e327579">37&nbsp;CFR 1.416(c)</a></b>
                        			(2). 
                     </p>
                     <div class="Section">
                        <h2 class="section1" id="d0e183664">
                           &nbsp;&nbsp;CHOICE OF EXAMINING AUTHORITY
                        </h2>
                        <p id="d0e183668"> For most applications, U.S.
                           				residents and nationals may choose to have the international preliminary examination
                           				done by the EPO if the EPO served as the International Searching Authority (ISA).
                           				However, for certain applications including one or more claims directed to the field
                           				of biotechnology, the field of business methods or the field of telecommunication,
                           				the EPO will not act as a competent IPEA. See <b><a href="s1865.html#d0e183713">MPEP §
                                 					1865.01</a></b> . 
                        </p>
                        <p id="d0e183674">U.S. residents and nationals may
                           				also choose to have the international preliminary examination done by the
                           				KIPO.
                        </p>
                        <p id="d0e183677"> The IPEA/US will serve as
                           				International Preliminary Examining Authority for U.S. residents and nationals if
                           				the U.S. , EPO , or KIPO served as ISA and the international application was filed
                           				in the U.S. Receiving Office or the International Bureau as receiving Office. 
                        </p>
                        <p id="d0e183689">The IPEA/US will also serve as
                           				International Preliminary Examining Authority for residents or nationals of
                           				Barbados, Brazil, Egypt, India, Israel, Mexico, New Zealand, the Philippines, Saint
                           				Lucia, South Africa, and Trinidad and Tobago if the U.S. was the International
                           				Searching Authority.
                        </p>
                        <div class="figure" id="d0e183692"><img src="graphics/1865-1.png" alt="Form PCT/IPEA/401 " width="770" height="896"></div>
                        <div class="figure" id="d0e183698"><img src="graphics/1865-2.png" alt="Form PCT/IPEA/401 (Second Sheet)" width="762" height="906"></div>
                        <div class="figure" id="d0e183703"><img src="graphics/1865-3.png" alt="Form PCT/IPEA/401 (last sheet)" width="762" height="906"></div>
                        <div class="figure" id="d0e183708"><img src="graphics/1865-4.png" alt="Form PCT/IPEA/401 Fee Calculation Sheet" width="762" height="906"></div>
                     </div>
                     <div class="Section">
                        <h1 class="page-title" id="d0e183713">1865.01
                           &nbsp;&nbsp;The European Patent Office as an International Preliminary
                           				Examining Authority [R-08.2012]
                        </h1>
                        <p id="d0e183717"> The European Patent Office (EPO)
                           				has expressed the following limitations concerning its competency to act as an
                           				International Preliminary Examining Authority (IPEA). For updates or possible
                           				changes to these limitations, applicants should consult the PCT Newsletter which is
                           				available in electronic form from the web site (www.wipo.int/pct/en/newslett/) of
                           				the World Intellectual Property Organization. 
                        </p>
                        <div class="Section">
                           <h2 class="section1" id="d0e183725">I.
                              &nbsp;&nbsp;FIELD OF BIOTECHNOLOGY
                           </h2>
                           <p id="d0e183729"> The EPO is not a competent
                              					authority within the meaning of PCT Article <b><a href="mpep-9025-appx-t.html#d0e363461">16</a></b> (3)(b)
                              					and PCT Article <b><a href="mpep-9025-appx-t.html#d0e364050">32</a></b> (3), and will not carry
                              					out international preliminary examination in respect of any international
                              					application filed before January 1, 2004, where the corresponding demand was
                              					filed with the EPO on or after March 1, 2002, if the application: (A) was filed
                              					with the USPTO as receiving Office by a national or resident of the U.S.; or (B)
                              					was filed in the International Bureau (IB) as receiving Office by a national or
                              					resident of the U.S. (provided the application did not also identify as an
                              					applicant at its time of filing a national or resident of a European Patent
                              					Convention (EPC) Contracting State); where the application contains one or more
                              					claims relating to the field of biotechnology as defined by the following units
                              					of the International Patent Classification: 
                           </p>
                           <table id="d0e183738">
                              <caption></caption>
                              <tbody id="d0e183746" style="vertical-align:">
                                 <tr id="d0e183748" style="vertical-align:">
                                    <td id="d0e183750">C12M</td>
                                    <td id="d0e183753">Apparatus for enzymology or
                                       									microbiology
                                    </td>
                                 </tr>
                                 <tr id="d0e183757" style="vertical-align:">
                                    <td id="d0e183759">C12N</td>
                                    <td id="d0e183762">Micro-organisms or enzymes;
                                       									compositions thereof
                                    </td>
                                 </tr>
                                 <tr id="d0e183766" style="vertical-align:">
                                    <td id="d0e183768">C12P</td>
                                    <td id="d0e183771">Fermentation or enzyme-using
                                       									processes to synthesise a desired chemical compound or
                                       									composition or to separate optical isomers from a racemic
                                       									mixture
                                    </td>
                                 </tr>
                                 <tr id="d0e183775" style="vertical-align:">
                                    <td id="d0e183777">C12Q</td>
                                    <td id="d0e183780">Measuring or testing processes
                                       									involving enzymes or micro-organisms; compositions or test
                                       									papers therefor; processes of preparing such compositions;
                                       									condition-responsive control in microbiological or enzymological
                                       									processes
                                    </td>
                                 </tr>
                                 <tr id="d0e183784" style="vertical-align:">
                                    <td id="d0e183786">C07K</td>
                                    <td id="d0e183789">Peptides</td>
                                 </tr>
                                 <tr id="d0e183793" style="vertical-align:">
                                    <td id="d0e183795">G01N 33/50 (including
                                       									subdivisions)
                                    </td>
                                    <td id="d0e183798">Chemical analysis of biological
                                       									material, e.g. blood, urine; testing involving biospecific
                                       									ligand binding methods; immunological testing
                                    </td>
                                 </tr>
                                 <tr id="d0e183802" style="vertical-align:">
                                    <td id="d0e183804">A61K 39</td>
                                    <td id="d0e183807">Medicinal preparations
                                       									containing antigens or antibodies
                                    </td>
                                 </tr>
                                 <tr id="d0e183811" style="vertical-align:">
                                    <td id="d0e183813">A61K 48</td>
                                    <td id="d0e183816">Medicinal preparations
                                       									containing genetic material which is inserted into cells of the
                                       									living body to treat genetic diseases; Gene therapy
                                    </td>
                                 </tr>
                                 <tr id="d0e183820" style="vertical-align:">
                                    <td id="d0e183822">A01H</td>
                                    <td id="d0e183825">New plants or processes for
                                       									obtaining them; plant reproduction by tissue culture
                                       									techniques
                                    </td>
                                 </tr>
                              </tbody>
                           </table>
                           <p id="d0e183831">For information, U.S. classes
                              					covering the corresponding subject matter are listed below:
                           </p>
                           <table id="d0e183834">
                              <caption></caption>
                              <tbody id="d0e183844" style="vertical-align:">
                                 <tr id="d0e183846" style="vertical-align:">
                                    <td id="d0e183848"></td>
                                    <td id="d0e183850">424</td>
                                    <td id="d0e183853">Drug, bio-affecting and body
                                       									treating compositions
                                    </td>
                                 </tr>
                                 <tr id="d0e183857" style="vertical-align:">
                                    <td id="d0e183859"></td>
                                    <td id="d0e183861">435</td>
                                    <td id="d0e183864">Chemistry: molecular biology and
                                       									microbiology
                                    </td>
                                 </tr>
                                 <tr id="d0e183868" style="vertical-align:">
                                    <td id="d0e183870"></td>
                                    <td id="d0e183872">436</td>
                                    <td id="d0e183875">Chemistry: analytical and
                                       									immunological testing
                                    </td>
                                 </tr>
                                 <tr id="d0e183879" style="vertical-align:">
                                    <td id="d0e183881"></td>
                                    <td id="d0e183883">514</td>
                                    <td id="d0e183886">Drug, bio-affecting and body
                                       									treating compositions
                                    </td>
                                 </tr>
                                 <tr id="d0e183890" style="vertical-align:">
                                    <td id="d0e183892"></td>
                                    <td id="d0e183894">530</td>
                                    <td id="d0e183897">Chemistry: natural resins or
                                       									derivatives; peptides or proteins; lignins or reaction products
                                       									thereof
                                    </td>
                                 </tr>
                                 <tr id="d0e183901" style="vertical-align:">
                                    <td id="d0e183903"></td>
                                    <td id="d0e183905">536</td>
                                    <td id="d0e183908">Organic compounds–part of the
                                       									class 532-570 series
                                    </td>
                                 </tr>
                                 <tr id="d0e183912" style="vertical-align:">
                                    <td id="d0e183914"></td>
                                    <td id="d0e183916">800</td>
                                    <td id="d0e183919">Multicellular living organisms
                                       									and unmodified parts thereof
                                    </td>
                                 </tr>
                                 <tr id="d0e183923" style="vertical-align:">
                                    <td id="d0e183925"></td>
                                    <td id="d0e183927">930</td>
                                    <td id="d0e183930">Peptide or protein
                                       									sequence
                                    </td>
                                 </tr>
                              </tbody>
                           </table>
                        </div>
                        <div class="Section">
                           <h2 class="section1" id="d0e183936">II.
                              &nbsp;&nbsp;FIELD OF BUSINESS METHODS
                           </h2>
                           <p id="d0e183940"> The EPO is not a competent
                              					authority within the meaning of PCT Article <b><a href="mpep-9025-appx-t.html#d0e363461">16</a></b> (3)(b)
                              					and PCT Article <b><a href="mpep-9025-appx-t.html#d0e364050">32</a></b> (3), and will not carry
                              					out international preliminary examination in respect of any international
                              					application where the corresponding demand was filed with the EPO on or after
                              					March 1, 2002, if the application: (A) is filed with the USPTO as receiving
                              					Office by a national or resident of the U.S.; or (B) is filed in the IB as
                              					receiving Office by a national or resident of the U.S. (provided the application
                              					does not also identify as an applicant at its time of filing a national or
                              					resident of an EPC Contracting State); where the application contains one or
                              					more claims relating to the field of business methods as defined by the
                              					following units of the International Patent Classification: 
                           </p>
                           <table id="d0e183949">
                              <caption></caption>
                              <tbody id="d0e183957" style="vertical-align:">
                                 <tr id="d0e183959" style="vertical-align:">
                                    <td id="d0e183961"> G06Q </td>
                                    <td id="d0e183966">Data processing systems or
                                       									methods, specially adapted for administrative, commercial,
                                       									financial, managerial, supervisory or forecasting purposes;
                                       									systems or methods specially adapted for administrative,
                                       									commercial, financial, managerial, supervisory or forecasting
                                       									purposes, not otherwise provided for
                                    </td>
                                 </tr>
                                 <tr id="d0e183970" style="vertical-align:">
                                    <td id="d0e183972">G06Q 10/00</td>
                                    <td id="d0e183975">Administration, e.g., office
                                       									automation or reservations; Management, e.g., resource or
                                       									project management
                                    </td>
                                 </tr>
                                 <tr id="d0e183979" style="vertical-align:">
                                    <td id="d0e183981">G06Q 30/00</td>
                                    <td id="d0e183984">Commerce, e.g., marketing,
                                       									shopping, billing, auctions or e-commerce
                                    </td>
                                 </tr>
                                 <tr id="d0e183988" style="vertical-align:">
                                    <td id="d0e183990">G06Q 40/00</td>
                                    <td id="d0e183993">Finance, e.g., banking,
                                       									investment or tax processing; Insurance, e.g., risk analysis or
                                       									pensions
                                    </td>
                                 </tr>
                                 <tr id="d0e183997" style="vertical-align:">
                                    <td id="d0e183999">G06Q 50/00</td>
                                    <td id="d0e184002">Systems or methods specially
                                       									adapted for a specific business sector, e.g., health care,
                                       									utilities, tourism or legal services
                                    </td>
                                 </tr>
                                 <tr id="d0e184006" style="vertical-align:">
                                    <td id="d0e184008">G06Q 90/00</td>
                                    <td id="d0e184011">Systems or methods specially
                                       									adapted for administrative, commercial, financial, managerial,
                                       									supervisory or forecasting purposes, not involving significant
                                       									data processing
                                    </td>
                                 </tr>
                                 <tr id="d0e184015" style="vertical-align:">
                                    <td id="d0e184017">G06Q 99/00</td>
                                    <td id="d0e184020"> Subject matter not provided for
                                       									in other groups of this subclass. 
                                    </td>
                                 </tr>
                              </tbody>
                           </table>
                           <p id="d0e184027">For information, the U.S.
                              					class covering the corresponding subject matter is listed below:
                           </p>
                           <table id="d0e184030">
                              <caption></caption>
                              <tbody id="d0e184038" style="vertical-align:">
                                 <tr id="d0e184040" style="vertical-align:">
                                    <td id="d0e184042">705</td>
                                    <td id="d0e184045">Data processing: financial,
                                       									business practice, management, or cost/price
                                       									determination
                                    </td>
                                 </tr>
                              </tbody>
                           </table>
                        </div>
                        <div class="Section">
                           <h2 class="section1" id="d0e184051">III.
                              &nbsp;&nbsp;FIELD OF TELECOMMUNICATION
                           </h2>
                           <p id="d0e184055"> The EPO is not a competent
                              					authority within the meaning of PCT Article <b><a href="mpep-9025-appx-t.html#d0e363461">16</a></b> (3)(b)
                              					and PCT Article <b><a href="mpep-9025-appx-t.html#d0e364050">32</a></b> (3), and will not carry
                              					out international preliminary examination in respect of any international
                              					application where the corresponding demand is filed with the EPO on or after
                              					March 1, 2002, and before July 1, 2004, where the application: (A) is filed with
                              					the USPTO as receiving Office by a national or resident of the U.S.; or (B) is
                              					filed in the IB as receiving Office by a national or resident of the U.S.
                              					(provided the application does not also identify as an applicant at its time of
                              					filing a national or resident of an EPC Contracting State); where the
                              					application contains one or more claims relating to the field of
                              					telecommunication as defined by the following unit of the International Patent
                              					Classification: 
                           </p>
                           <table id="d0e184064">
                              <caption></caption>
                              <tbody id="d0e184072" style="vertical-align:">
                                 <tr id="d0e184074" style="vertical-align:">
                                    <td id="d0e184076">H04</td>
                                    <td id="d0e184079">Electric communication technique
                                       									with the exception of H04N: Pictorial communication, e.g.
                                       									television
                                    </td>
                                 </tr>
                              </tbody>
                           </table>
                           <p id="d0e184085">For information, the U.S.
                              					classes covering the corresponding subject matter are listed
                              					below:
                           </p>
                           <table id="d0e184088">
                              <caption></caption>
                              <tbody id="d0e184098" style="vertical-align:">
                                 <tr id="d0e184100" style="vertical-align:">
                                    <td id="d0e184102"></td>
                                    <td id="d0e184104">370</td>
                                    <td id="d0e184107">Multiplex communications</td>
                                 </tr>
                                 <tr id="d0e184111" style="vertical-align:">
                                    <td id="d0e184113"></td>
                                    <td id="d0e184115">375</td>
                                    <td id="d0e184118">Pulse or digital
                                       									communications
                                    </td>
                                 </tr>
                                 <tr id="d0e184122" style="vertical-align:">
                                    <td id="d0e184124"></td>
                                    <td id="d0e184126">379</td>
                                    <td id="d0e184129">Telephonic communication</td>
                                 </tr>
                                 <tr id="d0e184133" style="vertical-align:">
                                    <td id="d0e184135"></td>
                                    <td id="d0e184137">380</td>
                                    <td id="d0e184140">Cryptography</td>
                                 </tr>
                                 <tr id="d0e184144" style="vertical-align:">
                                    <td id="d0e184146"></td>
                                    <td id="d0e184148">381</td>
                                    <td id="d0e184151">Electrical audio signal
                                       									processing systems and devices
                                    </td>
                                 </tr>
                                 <tr id="d0e184155" style="vertical-align:">
                                    <td id="d0e184157"></td>
                                    <td id="d0e184159">455</td>
                                    <td id="d0e184162">
                                       <p id="d0e184163">Telecommunications</p>
                                    </td>
                                 </tr>
                              </tbody>
                           </table>
                           <p id="d0e184169"> Demands for international
                              					preliminary examination submitted to a non-competent authority are subject to
                              					PCT Rule <b><a href="mpep-9025-appx-t.html#d0e374126">59.3</a></b> . Applicants filing
                              					demands with the EPO in applications directed to the above subject matter will
                              					receive a notice from the EPO indicating that the demand is being forwarded to
                              					the IPEA/US under PCT Rule <b><a href="mpep-9025-appx-t.html#d0e374126">59.3</a></b> (f). Any fees paid by
                              					the applicant to the EPO will be refunded to the applicant. Applicants have one
                              					month from the date of receipt of the demand transmitted to the IPEA under PCT
                              					Rule <b><a href="mpep-9025-appx-t.html#d0e374126">59.3</a></b> to pay the handling
                              					fee (PCT Rule <b><a href="mpep-9025-appx-t.html#d0e373786">57</a></b> and 37 CFR
                              						<b><a href="mpep-9020-appx-r.html#d0e328929">1.482</a></b> (b)) and the
                              					preliminary examination fee (PCT Rule <b><a href="mpep-9025-appx-t.html#d0e373909">58</a></b> and 37
                              					CFR <b><a href="mpep-9020-appx-r.html#d0e328929">1.482</a></b> (a)). See PCT Rules
                              						<b><a href="mpep-9025-appx-t.html#d0e373835">57.3</a></b> and <b><a href="mpep-9025-appx-t.html#d0e373916">58.1</a></b> (b). 
                           </p>
                        </div>
                     </div>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title">&nbsp;</h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s1801.html">1801-Basic Patent Cooperation Treaty (PCT) Principles</a></li>
               <li xmlns=""><a href="s1802.html">1802-PCT Definitions</a></li>
               <li xmlns=""><a href="s1803.html">1803-Reservations Under the PCT Taken by the United States of America</a></li>
               <li xmlns=""><a href="s1804.html">1804-[Reserved]</a></li>
               <li xmlns=""><a href="s1805.html">1805-Where To File an International Application</a></li>
               <li xmlns=""><a href="s1806.html">1806-[Reserved]</a></li>
               <li xmlns=""><a href="s1807.html">1807-Agent or Common Representative and General Power of Attorney</a></li>
               <li xmlns=""><a href="s1808.html">1808-Change in or Revocation of the Appointment of an Agent or a Common Representative</a></li>
               <li xmlns=""><a href="s1809.html">1809-[Reserved]</a></li>
               <li xmlns=""><a href="s1810.html">1810-Filing Date Requirements</a></li>
               <li xmlns=""><a href="s1811.html">1811-[Reserved]</a></li>
               <li xmlns=""><a href="s1812.html">1812-Elements of the International Application</a></li>
               <li xmlns=""><a href="s1813 - 1816.html">1813 - 1816-[Reserved]</a></li>
               <li xmlns=""><a href="s1817.html">1817-PCT Member States</a><ul>
                     <li><a href="s1817.html#d0e167497">1817.01-Designation of States in International Applications Having an International Filing Date On or After January 1, 2004</a><ul style="list-style-type: none">
                           <li><a href="s1817.html#d0e167644">1817.01(a)-Designation of States and Precautionary Designations in International Applications Having an International Filing Date Before
                                 January 1, 2004</a></li>
                        </ul>
                     </li>
                     <li><a href="s1817.html#d0e167827">1817.02-Continuation or Continuation-in-Part Indication in the Request</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1818.html">1818-[Reserved]</a></li>
               <li xmlns=""><a href="s1819.html">1819-Earlier Search</a></li>
               <li xmlns=""><a href="s1820.html">1820-Signature of Applicant</a></li>
               <li xmlns=""><a href="s1821.html">1821-The Request</a></li>
               <li xmlns=""><a href="s1822.html">1822-[Reserved]</a></li>
               <li xmlns=""><a href="s1823.html">1823-The Description</a><ul>
                     <li><a href="s1823.html#d0e168618">1823.01-Reference to Deposited Biological Material</a></li>
                     <li><a href="s1823.html#d0e169024">1823.02-Nucleotide and/or Amino Acid Sequence Listings, and Tables Related to Sequence Listings</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1824.html">1824-The Claims</a></li>
               <li xmlns=""><a href="s1825.html">1825-The Drawings</a></li>
               <li xmlns=""><a href="s1826.html">1826-The Abstract</a></li>
               <li xmlns=""><a href="s1827.html">1827-Fees</a><ul>
                     <li><a href="s1827.html#d0e170417">1827.01-Refund of International Application Fees</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1828.html">1828-Priority Claim and Document</a><ul>
                     <li><a href="s1828.html#d0e170589">1828.01-Restoration of the Right of Priority</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1829.html">1829-[Reserved]</a></li>
               <li xmlns=""><a href="s1830.html">1830-International Application Transmittal Letter</a></li>
               <li xmlns=""><a href="s1831.html">1831-[Reserved]</a></li>
               <li xmlns=""><a href="s1832.html">1832-License Request for Foreign Filing Under the PCT</a></li>
               <li xmlns=""><a href="s1833.html">1833-[Reserved]</a></li>
               <li xmlns=""><a href="s1834.html">1834-Correspondence</a><ul>
                     <li><a href="s1834.html#d0e170909">1834.01-Use of Telegraph, Teleprinter, Facsimile Machine</a></li>
                     <li><a href="s1834.html#d0e170997">1834.02-Irregularities in the Mail Service</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1835.html">1835-[Reserved]</a></li>
               <li xmlns=""><a href="s1836.html">1836-Rectification of Obvious Mistakes</a></li>
               <li xmlns=""><a href="s1837-1839.html">1837-1839-[Reserved]</a></li>
               <li xmlns=""><a href="s1840.html">1840-The International Searching Authority</a><ul>
                     <li><a href="s1840.html#d0e171588">1840.01-The European Patent Office as an International Searching Authority</a></li>
                     <li><a href="s1840.html#d0e171975">1840.02-The Korean Intellectual Property Office as an International Searching Authority</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1841.html">1841-[Reserved]</a></li>
               <li xmlns=""><a href="s1842.html">1842-Basic Flow Under the PCT</a></li>
               <li xmlns=""><a href="s1843.html">1843-The International Search</a><ul>
                     <li><a href="s1843.html#d0e172347">1843.01-Prior Art for Chapter I Processing</a></li>
                     <li><a href="s1843.html#d0e172603">1843.02-Certain Subject Matter Need Not Be Searched</a></li>
                     <li><a href="s1843.html#d0e172803">1843.03-No Search Required if Claims Are Unclear</a></li>
                     <li><a href="s1843.html#d0e172835">1843.04-Procedure for Claims Not Required To Be Searched and for Claims That Are Unclear</a></li>
                     <li><a href="s1843.html#d0e172870">1843.05-Time Limit for Establishing the International Search Report and the Written Opinion of the International Searching Authority</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1844.html">1844-The International Search Report</a><ul>
                     <li><a href="s1844.html#d0e172999">1844.01-Preparing the International Search Report (Form PCT/ISA/210)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1845.html">1845-Written Opinion of the International Searching Authority</a><ul>
                     <li><a href="s1845.html#d0e173906">1845.01-Preparing the Written Opinion of the International Searching Authority (Form PCT/ISA/237)</a></li>
                     <li><a href="s1845.html#d0e174931">1845.02-Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority,
                           or the Declaration (Form PCT/ISA/220)</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1846.html">1846-Sections of the Articles, Regulations, and Administrative Instructions Under the PCT Relevant to the International Searching
                     Authority</a></li>
               <li xmlns=""><a href="s1847.html">1847-[Reserved]</a></li>
               <li xmlns=""><a href="s1848.html">1848-Sequence Listings and Tables Related to Sequence Listings</a></li>
               <li xmlns=""><a href="s1849.html">1849-[Reserved]</a></li>
               <li xmlns=""><a href="s1850.html">1850-Unity of Invention Before the International Searching Authority</a></li>
               <li xmlns=""><a href="s1851.html">1851-Identification of Patent Documents</a></li>
               <li xmlns=""><a href="s1852.html">1852-Taking Into Account Results of Earlier Search(es)</a></li>
               <li xmlns=""><a href="s1853.html">1853-Amendment Under PCT Article 19</a></li>
               <li xmlns=""><a href="s1854-1856.html">1854-1856-[Reserved]</a></li>
               <li xmlns=""><a href="s1857.html">1857-International Publication</a><ul>
                     <li><a href="s1857.html#d0e182117">1857.01-Prior Art Effect of the International Publication</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1858.html">1858-[Reserved]</a></li>
               <li xmlns=""><a href="s1859.html">1859-Withdrawal of International Application, Designations, or Priority Claims</a></li>
               <li xmlns=""><a href="s1860.html">1860-International Preliminary Examination Procedure for Applications Having an International Filing Date On or After January 1,
                     2004</a><ul>
                     <li><a href="s1860.html#d0e182787">1860.01-International Preliminary Examination Procedure for Applications Having an International Filing Date Before January 1, 2004</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1861.html">1861-[Reserved]</a></li>
               <li xmlns=""><a href="s1862.html">1862-Agreement With the International Bureau To Serve as an International Preliminary Examining Authority</a></li>
               <li xmlns=""><a href="s1863.html">1863-[Reserved]</a></li>
               <li xmlns=""><a href="s1864.html">1864-The Demand and Preparation for Filing of Demand</a><ul>
                     <li><a href="s1864.html#d0e183157">1864.01-Amendments Filed Under PCT Article 34</a></li>
                     <li><a href="s1864.html#d0e183297">1864.02-Applicant’s Right To File a Demand</a></li>
                     <li><a href="s1864.html#d0e183417">1864.03-States Which May Be Elected</a></li>
                     <li><a href="s1864.html#d0e183461">1864.04-Agent’s Right To Act</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1865.html">1865-Filing of Demand</a><ul>
                     <li><a href="s1865.html#d0e183713">1865.01-The European Patent Office as an International Preliminary Examining Authority</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1866.html">1866-Filling in of Headings on Chapter II Forms</a></li>
               <li xmlns=""><a href="s1867.html">1867-Preliminary Examination Fees</a></li>
               <li xmlns=""><a href="s1868.html">1868-Correction of Defects in the Demand</a></li>
               <li xmlns=""><a href="s1869.html">1869-Notification to International Bureau of Demand</a></li>
               <li xmlns=""><a href="s1870.html">1870-Priority Document and Translation Thereof</a></li>
               <li xmlns=""><a href="s1871.html">1871-Processing Amendments Filed Under Article 19 and Article 34 Prior to or at the Start of International Preliminary Examination
                     in International Applications Having an International Filing Date On or After January 1, 2004</a><ul>
                     <li><a href="s1871.html#d0e184948">1871.01-Processing Amendments Filed Under Article 19 and Article 34 Prior to or at the Start of International Preliminary Examination
                           in International Applications Having an International Filing Date Before January 1, 2004</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1872.html">1872-Availability of the International Application File for International Preliminary Examination by the Examining Corps</a></li>
               <li xmlns=""><a href="s1873.html">1873-[Reserved]</a></li>
               <li xmlns=""><a href="s1874.html">1874-Determination if International Preliminary Examination Is Required and Possible</a></li>
               <li xmlns=""><a href="s1875.html">1875-Unity of Invention Before the International Preliminary Examining Authority</a><ul>
                     <li><a href="s1875.html#d0e185391">1875.01-Preparation of Invitation Concerning Unity</a></li>
                     <li><a href="s1875.html#d0e185503">1875.02-Reply to Invitation Concerning Lack of Unity of Invention</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1876.html">1876-Notation of Errors and Informalities by the Examiner</a><ul>
                     <li><a href="s1876.html#d0e185657">1876.01-Request for Rectification and Notification of Action Thereon</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1877.html">1877-Nucleotide and/or Amino Acid Sequence Listings During the International Preliminary Examination</a></li>
               <li xmlns=""><a href="s1878.html">1878-Preparation of the Written Opinion of the International Preliminary Examining Authority in International Applications Having
                     an International Filing Date On or After January 1, 2004</a><ul>
                     <li><a href="s1878.html#d0e186282">1878.01-Preparation of the Written Opinion in International Applications Having an International Filing Date Before January 1, 2004</a><ul style="list-style-type: none">
                           <li><a href="s1878.html#d0e187509">1878.01(a)-Prior Art for Purposes of the Written Opinion and the International Preliminary Examination Report</a><ul>
                                 <li><a href="s1878.html#d0e187677">1878.01(a)(1)-Novelty for Purposes of the Written Opinion and the International Preliminary Examination Report</a></li>
                                 <li><a href="s1878.html#d0e187723">1878.01(a)(2)-Inventive Step for Purposes of the Written Opinion and the International Preliminary Examination Report</a></li>
                                 <li><a href="s1878.html#d0e187807">1878.01(a)(3)-Industrial Applicability for Purposes of the Written Opinion and the International Preliminary Examination Report</a></li>
                              </ul>
                           </li>
                        </ul>
                     </li>
                     <li><a href="s1878.html#d0e187853">1878.02-Reply to the Written Opinion of the ISA or IPEA</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1879.html">1879-Preparation of the International Preliminary Examination Report</a><ul>
                     <li><a href="s1879.html#d0e188619">1879.01-Time Limit for Preparing Report in International Applications Having an International Filing Date On or After January 1, 2004</a><ul style="list-style-type: none">
                           <li><a href="s1879.html#d0e188804">1879.01(a)-Time Limit for Preparing Report in International Application Having an International Filing Date Before January 1, 2004</a></li>
                        </ul>
                     </li>
                     <li><a href="s1879.html#d0e188956">1879.02-Transmittal of the International Preliminary Examination Report</a></li>
                     <li><a href="s1879.html#d0e189042">1879.03-Translations</a></li>
                     <li><a href="s1879.html#d0e189228">1879.04-Confidential Nature of the Report</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1880.html">1880-Withdrawal of Demand or Election</a></li>
               <li xmlns=""><a href="s1881.html">1881-Receipt of Notice of Election and Preliminary Examination Report by the United States Patent and Trademark Office</a></li>
               <li xmlns=""><a href="s1882-1892.html">1882-1892-[Reserved]</a></li>
               <li xmlns=""><a href="s1893.html">1893-National Stage (U.S. National Application Filed Under 35 U.S.C. 371)</a><ul>
                     <li><a href="s1893.html#d0e189843">1893.01-Commencement and Entry</a><ul style="list-style-type: none">
                           <li><a href="s1893.html#d0e190008">1893.01(a)-Entry via the U.S. Designated or Elected Office</a><ul>
                                 <li><a href="s1893.html#d0e190240">1893.01(a)(1)-Submissions Required by 30 Months from the Priority Date</a></li>
                                 <li><a href="s1893.html#d0e190345">1893.01(a)(2)-Article 19 Amendment (Filed With the International Bureau)</a></li>
                                 <li><a href="s1893.html#d0e190402">1893.01(a)(3)-Article 34 Amendments (Filed with the International Preliminary Examining Authority)</a></li>
                              </ul>
                           </li>
                           <li><a href="s1893.html#d0e190492">1893.01(c)-Fees</a></li>
                           <li><a href="s1893.html#d0e190635">1893.01(d)-Translation</a></li>
                           <li><a href="s1893.html#d0e190737">1893.01(e)-Oath/Declaration</a></li>
                        </ul>
                     </li>
                     <li><a href="s1893.html#d0e191079">1893.02-Abandonment</a></li>
                     <li><a href="s1893.html#d0e191121">1893.03-Prosecution of U.S. National Stage Applications Before the Examiner</a><ul style="list-style-type: none">
                           <li><a href="s1893.html#d0e191193">1893.03(a)-How To Identify That an Application Is a U.S. National Stage Application</a></li>
                           <li><a href="s1893.html#d0e191308">1893.03(b)-The Filing Date of a U.S. National Stage Application</a></li>
                           <li><a href="s1893.html#d0e191506">1893.03(c)-The Priority Date, Priority Claim, and Priority Papers for a U.S. National Stage Application</a></li>
                           <li><a href="s1893.html#d0e191885">1893.03(d)-Unity of Invention</a></li>
                           <li><a href="s1893.html#d0e192440">1893.03(e)-Documents Received from the International Bureau and Placed in a U.S. National Stage Application File</a><ul>
                                 <li><a href="s1893.html#d0e192601">1893.03(e)(1)-Title of the Invention</a></li>
                              </ul>
                           </li>
                           <li><a href="s1893.html#d0e192624">1893.03(f)-Drawings and PCT Rule 11</a></li>
                           <li><a href="s1893.html#d0e192639">1893.03(g)-Information Disclosure Statement in a National Stage Application</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1894.html">1894-[Reserved]</a></li>
               <li xmlns=""><a href="s1895.html">1895-A Continuation , Divisional, or Continuation- in- Part Application of a PCT Application Designating the United States</a><ul>
                     <li><a href="s1895.html#d0e192774">1895.01-Handling of and Considerations in the Handling of Continuations, Divisions, and Continuations-In-Part of PCT Applications</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s1896.html">1896-The Differences Between a National Application Filed Under 35 U.S.C. 111(a) and a National Stage Application Submitted Under
                     35 U.S.C. 371</a></li>
            </ul>  </div>
         </div>
      </div>  </div>
      <!-- Footer Navigation: /includes/general/footer2.html -->

<!-- Used in: MPEP, CPC -->

<!-- ID = $Id: footer2.html 3354 2013-04-23 18:43:33Z janaki $ -->

<!-- URL = $URL: https://dev-wmb-svn.etc.uspto.gov/repos/live/active_content/trunk/includes/general/footer2.html $ -->





  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:33 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>